New Evidence to Support Optimal, Early Nutrition Intervention to Improve Patient Outcomes

Program Date: 30 March 2020
Publication Date: 11 June 2020
Continuing Education Units: Nurse Contact: 1.0; Dietitian CPEU: 1.0

Course Description:

In this course, you’ll summarize new evidence supporting the benefits of early nutrition intervention in at-risk patient populations; illustrate the health, economic, and cost benefits of nutrition intervention; and evaluate the implementation of new evidence and science into clinical practice. Originally presented at the 2020 virtual ASPEN Conference.

Course Objectives:

•Summarize new evidence supporting the benefits of early nutrition intervention in at-risk patient populations.
•Illustrate the health, economic and cost benefits of nutrition intervention.
•Evaluate the implementation of new evidence and science into clinical practice.
  • CDR Level: 1
  • Performance Indicators: 4.2.7, 6.1.2, 8.3.4
  • Run Time: 50

Course Instructor Bio(s)

Headshot placeholder

Nicolaas Deutz, MD, PhD

Director, Center for Translational Research
Health and Kinesiology
Texas A&M University
College Station, TX, USA
Dr Nicolaas Deutz, MD, PhD currently serves as Director for the Center for Translational Research in Aging and Longevity (CTRAL). For more than 30 years, his research background and expertise focus on nutrition, metabolism, and physiology studies involving the use of stable isotope methodologies, both in humans and animals. Dr Deutz has extensive experience with isotopic calculations, validation and data interpretation. The stable isotope approaches are used in several studies to unravel the metabolic changes in patients with chronic diseases (i.e., chronic obstructive pulmonary disease, cancer, cystic fibrosis, chronic heart failure, obstructive sleep apnea, mild cognitive impairment and dementia, autism spectrum disorder). This research leads to new insights in protein and amino acid kinetics in subjects with chronic disease and resulted in specific recommendations to nutritional supplements as method for reducing muscle wasting. Recently, he started studying the anabolic effects of specialized nutritional supplements in different chronic diseases and models of disease. Using translational approaches is a logical extension of the body of his research in the field of protein and amino acids metabolism. Education: Dr. Deutz obtained his MD and PhD at the University of Amsterdam, Netherlands
Headshot placeholder

Philipp Schuetz, MD, MPH

Internal Medicine & Emergency Medicine
Medical University Department
Kantonsspital Aarau, Tellstrasse
Aarau, Switzerland
Philipp Schuetz was born in Switzerland and is a board-certified internist and endocrinologist. He obtained a Master of Public Health (MPH) at the Harvard School of Public Health Boston while doing clinical research at the Beth Israel Deaconess Medical Center (BIDMC). He currently has a professorship from the Swiss National Foundation and works clinically at the Medical University department at the Kantonsspital Aarau in the emergency department and the Endocrine unit; and is in charge of clinical studies focusing on clinical nutrition (EFFORT), as well as on improved triage and management of patients throughout their hospital stay with the use of novel biomarkers.

You Must LOG IN to Enroll


attended a live program?




continuing medical education courses